Field of Expertise
Blood cancers (Acute lymphoblastic leukemia, Acute myeloid leukemia, chronic myeloid leukemia, Chronic lymphocytic leukemia), Plasma cell disorders
Autologous and Allogeneic stem cell transplants (matched sibling donor, matched/mismatched unrelated donor, haploidentical donor, cord blood transplants). Trained at Vancouver General Hospital, British Columbia that performs more than 300 stem cell transplants a year.
Childhood cancers
Immunotherapy
Targeted therapy
Talks & Publications
Danthala M, Kallur KG, Prashant GR, Rajkumar K, Rao MR. 177 Lu-DOTATATE therapy in patients with neuroendocrine tumours: 5 years’ experience from a tertiary cancer care centre in India. European journal of nuclear medicine and molecular imaging. 2014 Jul 1;41(7):1319-26.
Danthala M, Gundeti S, Kuruva SP, Puligundla KC, Adusumilli P, Karnam AP, Bala S, Konatam ML, Maddali LS, Digumarti RR. Generic imatinib in chronic myeloid leukemia: survival of the cheapest. Clinical Lymphoma Myeloma and Leukemia. 2017 Jul 1;17(7):457-62.
Danthala M, Gundeti S, Maddali LS, Pillai A, Puligundla KC, Adusumilli RP. Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care center in India. South Asian journal of cancer. 2016 Oct;5(4):176.
Danthala M, Rajesh GR, Gundeti S, Raju GS, Chandran P, Srinivas ML. Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers. Indian Journal of Medical and Paediatric Oncology. 2018 Jul 1;39(3):292.
Danthala M, Lakshmaiah V. Correlative study of serum cystatin C levels with severity of acute ischemic stroke. Journal of Clinical and Biomedical Sciences J Clin Biomed Sci. 2013;3(4):188-92.
Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, Reddy N, Malipatil B, Sirigeri R, Prasad K, Reddy K, Danthala M, Udupa KS. Halving time of BCR-ABL1 in Chronic Myeloid Leukemia, Is it a better than day 90 value–Multicenter study from south India. Clinical Lymphoma Myeloma and Leukemia. 2019 Sep 30.
Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, Patil C, Anoop P, Reddy N, Anumula SK, Roopa SP, Danthala M. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Journal of global oncology. 2019 Dec;5:1-3.
Adusumilli P, Gundeti S, Danthala M, Pk C. 301P Long term survival and late side effects of paediatric Hodgkin lymphoma patients: a study from tertiary care centre in Southern India. Annals of Oncology. 2015 Dec 1;26(suppl_9):ix89-.
Puligundla CK, Gundeti S, Bala S, Pillai A, Adusumilli P, Danthala M, Konatam ML, Maddali LS. Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domain in CML Patients with Imatinib Treatment Failure-Data from a Large Tertiary Center in India. Blood 2016 vol: 128 (22) pp: 1910-1910.
Oral presentation/proffered paper: Additional chromosomal abnormalities in chronic myeloid leukemia: lest we forget. Presented at ESMO (European society of Medical Oncology) Asia 2016, Singapore.
Oral presentation: Generic Imatinib in Chronic Myeloid Leukemia: Survival of the cheapest. Presented at ASH 2016 (Annual American Society of Hematology conference), San Diego.
Paper presentation at KAPICON 2012 – “ Microalbuminuric Anemia “ – A Study of the relationship between Hemoglobin levels and Albuminuria in Diabetes.
Obesity and breast cancer: Association of serum adiponectin, leptin and adiponectin-leptin ratio as risk biomarkers. Presented at Annual Indian Society of Medical and Pediatric Oncology conference, 2016 at Delhi
Renal Reversibility in multiple myeloma: A race against the clock! Presented at Myeloma: State of the art, 2016, PGI Chandigarh
Philadelphia chromosome-positive acute lymphoblastic leukemia: 8 years’ experience from a tertiary care centre in India. Presented at Annual Asian Clinical Oncology society conference 2016, Delhi
Validation of an enhanced International Prognostic Index (NCCN-IPI) in patients with diffuse large B cell lymphoma in the Rituximab era: 7 years’ experience from a tertiary care centre in South India. Presented at ICON 2016.
Frontline Imatinib in chronic myeloid leukemia: a jewel in the crown, Presented at Hematocon 2016, Jaipur
Pediatric chronic myeloid leukemia: wise to generalize? Presented at ISMPOCON 2016, Delhi
Poster presentation at HEMATOCON 2015 - Monosomy 7 and Deletion 7q in Acute Myeloid Leukemia – M0/M1 with prior Myelodysplastic syndrome transformed from Fanconi Anemia – a case report
Poster presentation at APICON 2013 (National Conference) - Phenytoin induced Cerebellar Ataxia and Orofacial Dyskinesia in a rare case of Disseminated Cysticercosis.
